Breaking News

Upperton Pharma Solutions Completes New Sterile Manufacturing Facility

The 7,000 sq. ft facility will support the manufacturing of aseptic and terminally sterilized small-volume liquids and powders for parenteral, nasal, and pulmonary delivery.

Author Image

By: Charlie Sternberg

Associate Editor

L to R: Paul Kelsall (Director of Clinical Manufacturing), Nikki Whitfield (Chief Executive Officer), Ian Lafferty (Chief Technical Officer), Jon Austwick (Director of Quality & Compliance).

UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new purpose-built facility, which is in addition to the CDMO’s existing 50,000 sq. ft facility in Trent Gateway, was designed specifically in line with the revised EU GMP Annex-1 regulations. The 7,000 sq. ft facility will support the manufacturing of aseptic and terminally sterilized small-volume liquids and powders for pare...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters